Oral–Based Diagnostics, Volume 1098

Oral–based diagnostics have the potential to detect systemic disease and evidence of exposure to various harmful substances, as well as provide biomarkers of health and disease status. Integration of novel approaches to oral–based diagnostics is expanding to include genomics, proteomics, bioinformatics, and nanotechnology.
Improved technologies for diagnostics are resulting in more "user–friendly" methods. Efforts to translate bench assays to commercial products in the area of oral diagnostics have increased recently, as witnessed by the appearance of several new oral–based diagnostic products in the marketplace. Collaborative academic, government, and industry relationships in this arena are also forming, all of which will undoubtedly serve to rapidly advance the field.
This volume brings together contributions from leaders in the areas of toxicology, pathology, oral biology, dental research, and clinical medicine.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full–text access to the Annals online and discounts on print volumes. Please visit www.nyas.org/membership/main.asp for more information about becoming a member.

Spis treści:
Dedication to Irwin Mandel: Daniel Malamud.
Introduction: Daniel Malamud and R. Sam Niedbala.
Part I: Biochemistry/Physiology of Saliva: Implications for Diagnostics:.
1. Implications for Diagnostics in the Biochemistry and Physiology of Saliva: Arie V. Nieuw Amerongen, Antoon J. M. Ligtenberg, and Enno C. I. Veerman.
2. Point–of–Care Diagnostics Enter the Mouth: Lawrence A. Tabak.
3. Auto immune Diseases and Sjögren’s Syndrome: An Autoimmune Exocrinopathy: Philip C. Fox.
4. Salivary Proteome and Its Genetic Polymorphisms: Frank G. Oppenheim, Erdjan Salih, Walter L. Siqueira, Weimin Zhang, and Eva J. Helmerhorst.
Part II: Drug and Small Molecule Detection in Saliva:.
5. Interpretation of Oral Fluid Tests for Drugs of Abuse: Edward J. Cone and Marilyn A. Huestis.
6. Methamphetamine Disposition in Oral Fluid, Plasma, and Urine: Marilyn A. Huestis and Edward J. Cone.
7. Salivary α–Amylase in Biobehavioral Research: Recent Developments and Applications: Douglas A. Granger, Katie T. Kivlighan, Mona El–Sheikh, Elena Gordis, and Laura R. Stroud.
8. The Use of Oral Fluid for Therapeutic Drug Management: Clinical and Forensic Toxicology: Loralie J. Langman.
Part III: Meeting Unmet Needs in Diagnostics:.
9. Visualization and Other Emerging Technologies as Change Makers for Oral Cancer Prevention: Miriam P. Rosin, Catherine F. Poh, Martial Guillard, P. Michele Williams, Lewei Zhang, and Calum Macaulay.
10. Genomic Targets in Saliva: Bernhard G. Zimmermann, Noh Jin Park, and David T. Wong.
11. Saliva and the Clinical Pathology Laboratory: Michael A. Pesce and Steven L. Spitalnik.
Part IV: Oral Samples/Oral Diseases:.
12. Oral Diseases: From Detection to Diagnostics: Antoon J. M. Ligtenberg, Johannes J. De Soet, Enno C. I. Veerman, and Arie V. Nieuw Amerongen.
13. A Novel Caries Risk Test: Paul C. Denny, Patricia A. Denny, Jona Takashima, Joyce Galligan, and Mahvash Navazesh.
14. Analysis of Gingival Crevicular Fluid as Applied to the Diagnosis of Oral and Systemic Diseases: Ira B. Lamster and Joseph K. Ahlo.
15. Oral Fluid–Based Biomarkers of Alveolar Bone Loss in Periodontitis: Janet S. Kinney, Christoph A. Ramseier, and William V. Giannobile.
16. Human Breath Odors and Their Use in Diagnosis: Chris L. Whittle, Steven Fakharzadeh, Jason Eades, and George Preti .
Part V: Molecular and Protein Markers of Disease:.
17. Molecular and Protein Markers of Disease: Michael Glick.
18. Subclinical Cardiovascular Disease Markers Applicable to Studies of Oral Health: Multiethnic Study of Atherosclerosis: David R. Jacobs, Jr., and Richard S. Crow.
19. Do Salivary Antibodies Reliably Reflect Both Mucosal and Systemic Immunity?: Per Brandtzaeg.
20. Oxytocin: Behavioral Associations and Potential as a Salivary Biomarker: C. Sue Carter, Hossein Pournajafi–Nazarloo, Kristin M. Kramer, Toni E. Ziegler, Rosemary White–Traut, Deborah Bello, and Dorie Schwertz.
21. Human Saliva Proteome Analysis: Shen Hu, Joseph A. Loo, and David T. Wong.
Part VI: Horizons in Oral Diagnostics:.
22. Genomics and Proteomics: The Potential Role of Oral Diagnostics: Hans J. Tanke.
23. SPR Imaging–Based Salivary Diagnostics System for the Detection of Small Molecule Analytes: Elain Fu, Timothy Chinowsky, Kjell Nelson, Kyle Johnston, Thayne Edwards, Kristen Helton, Michael Grow, John W. Miller, and Paul Yager.
24. Saliva–Based Diagnostics Using 16S rRNA Microarrays and Microfluidics: E. Michelle Starke, James C. Smoot, Jer–Horng Wu, Wen–Tso Liu, Darrell Chandler, and David A. Stahl.
25. Integrated Microfluidic Platform for Oral Diagnostics: Amy E. Herr, Anson V. Hatch, William V. Giannobile, Daniel J. Throckmorton, Huu M. Tran, James S. Brennan, and Anup K. Singh.
26. Development of a Microfluidic Device for Detection of Pathogens in Oral Samples Using Upconverting Phosphor Technology (UPT): William R. Abrams, Cheryl A. Barber, Kurt McCann, Gary Tong, Zongyuan Y. Chen, Michael G. Mauk, Jing Wang, Alex Volkov, Pete Bourdelle, Paul L. A. M. Corstjens, Michel Zuiderwijk, Keith Kardos, Shang Li, Hans J. Tanke, R. Sam Niedbala, Daniel Malamud, and Haim Bau.
27. Microsensor Arrays for Saliva Diagnostics: David R. Walt, Timothy M. Blicharz, Ryan B. Hayman, David M. Rissin, Michaela Bo wden, Walter L. Siqueira, Eva J. Helmerhorst, Nerline Grand–Pierre, Frank G. Oppenheim, Jasvinder S. Bhatia, Frederic F. Little, and Jerome S. Brody.
28. Oral Fluid Nanosensor Test (OFNASET) with Advanced Electrochemical–Based Molecular Analysis Platform: Vincent Gau and David Wong.
29. Lab–on–a–Chip Methods for Point–of–Care Measurements of Salivary Biomarkers of Periodontitis: Nicolaos Christodoulides, Pierre N. Floriano, Craig S. Miller, Jeffrey L. Ebersole, Sanghamitra Mohanty, Priya Dharshan, Michael Griffin, Alexis Lennart, Karri L. Michael Ballard, Charles P. King, Jr., M. Chris Langub, Richard J. Kryscio, Mark V. Thomas, and John T. McDevitt.
Part VII: Short Papers:.
30. A Microfluidic System for Saliva–Based Detection of Infectious Diseases: Zongyuan Chen, Michael G. Mauk, Jing Wang, William R. Abrams, Paul L. A. M. Corstjens, R. Samuel Niedbala, Daniel Malamud, and Haim H. Bau.
31. Rapid Assay Format for Multiplex Detection of Humoral Immune Responses to Infectious Disease Pathogens (HIV, HCV, and TB): Paul L. A. M. Corstjens, Zongyuang Chen, Michel Zuiderwijk, Haim H. Bau, William R. Abrams, Daniel Malamud, R. Sam Niedbala, and Hans J. Tanke.
32. Patterns of Salivary Estradiol and Progesterone across the Menstrual Cycle: Beatrice K. Gandara, Linda Leresche, and Lloyd Mancl.
33. Layered Peptide Arrays: A Diverse Technique for Antibody Screening of Clinical Samples: Gallya Gannot, Michael A. Tangrea, Rodrigo F. Chuaqui, John W. Gillespie, and Michael R. Emmert–Buck.
34. Whole Saliva Proteolysis: Wealth of Information for Diagnostic Exploitation: Eva J. Helmerhorst.
35. Saliva–Based HIV Testing among Secondary School Students in Tanzania using the OraQuick® Rapid HIV1/2 Antibody Assay: Carol Holm–Hansen, Balthazar Nyombi, and Mramba Nyindo.
36. Lab–on–a–Chip Technologies for Oral–Based Cancer Screening and Diagnostics: Capabili